| Bioactivity | 5-Bromo-2',3',5'-tri-O-acetyluridine diacetate is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 5-Bromo-2',3',5'-tri-O-acetyluridine |
| CAS | 105659-32-3 |
| Formula | C15H17BrN2O9 |
| Molar Mass | 449.21 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
5-Bromo-2',3',5'-tri-O-acetyluridine
CAS: 105659-32-3 F: C15H17BrN2O9 W: 449.21
5-Bromo-2',3',5'-tri-O-acetyluridine diacetate is a purine nucleoside analog. Purine nucleoside analogs have broad antit
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.